Literature DB >> 2311630

A new case of hyperargininaemia: neurological and biochemical findings prior to and during dietary treatment.

M Brockstedt1, L M Smit, A J de Grauw, J M van der Klei-van Moorsel, C Jakobs.   

Abstract

We present clinical and biochemical data on a further patient with hyperargininaemia and the results of neurophysiological tests both before and during dietary treatment with an essential amino acid mixture. With normalisation of plasma arginine concentrations, neurological functions improved and brain stem auditory evoked potentials normalized suggesting a partially reversible central conduction disorder. Neuroradiological findings included cerebral cortical atrophy on computed tomography scan and patchy abnormal myelination on magnetic resonance imaging (MRI). The typical clinical picture is discussed with reference to published therapeutical trials.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311630     DOI: 10.1007/bf02171562

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Lysine supplementation in hyperargininemia.

Authors:  W M Pardridge
Journal:  J Pediatr       Date:  1977-12       Impact factor: 4.406

2.  Hyperargininaemia.

Authors:  I Antonozzi; V Leuzzi
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Hyperargininemia: effect of ornithine and lysine supplementation.

Authors:  S S Kang; P W Wong; M A Melyn
Journal:  J Pediatr       Date:  1983-11       Impact factor: 4.406

4.  Diagnosis and treatment of argininaemia. Characteristics of arginase in human erythrocytes and tissues.

Authors:  W Endres; R Schaller; Y S Shin
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  Argininemia treated from birth.

Authors:  S E Snyderman; C Sansaricq; P M Norton; F Goldstein
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

6.  A new case of arginase deficiency in a Spanish male.

Authors:  A Jordá; V Rubio; M Portolés; J Vilas; J García-Piño
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

7.  A new French-Canadian family affected by hyperargininaemia.

Authors:  I A Qureshi; J Letarte; R Ouellet; J Larochelle; B Lemieux
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

8.  Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet.

Authors:  S D Cederbaum; S J Moedjono; K N Shaw; M Carter; E Naylor; M Walzer
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

9.  Argininemia.

Authors:  S E Snyderman; C Sansaricq; W J Chen; P M Norton; S V Phansalkar
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

  9 in total
  3 in total

1.  Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.

Authors:  Xiao-Bo Liu; Jillian R Haney; Gloria Cantero; Jenna R Lambert; Marcos Otero-Garcia; Brian Truong; Andrea Gropman; Inma Cobos; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  JCI Insight       Date:  2019-09-05

2.  Hyperargininaemia: follow-up of a new case.

Authors:  P Scarpa; R Faggioli
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Molecular basis of phenotypic variation in patients with argininemia.

Authors:  T Uchino; S E Snyderman; M Lambert; I A Qureshi; S K Shapira; C Sansaricq; L M Smit; C Jakobs; I Matsuda
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.